SCHOTT Pharma
Christopher J. Cassidy has a wealth of experience in the pharmaceutical and medical packaging industry. Christopher J. currently holds the position of President at SCHOTT North America, Inc., as well as President at SCHOTT Pharma USA, Inc. Both roles involve overseeing the development and manufacturing of glass and specialty materials for drug containment and delivery systems. Prior to their current roles, Cassidy served as Vice President of Pharmaceutical Systems at SCHOTT North America, Inc. from 2014 to 2022. Christopher J. also held the position of VP Sales & Marketing, North America at Chesapeake Pharmaceutical Packaging from 2010 to 2014. Before that, they were the Director of Sales & Marketing for Helvoet Pharma's North American operations from 2005 to 2010. Cassidy started their career at Gerresheimer and served as the Director of the East Region & Export Sales from 1990 to 2005. Throughout their career, Cassidy has demonstrated their expertise in managing sales, marketing, and operations in the pharmaceutical packaging industry.
Christopher J. Cassidy attended Duke University from 1985 to 1989, where they earned a Bachelor of Arts degree in English & History.
This person is not in any offices
SCHOTT Pharma
1 followers
SCHOTT Pharma designs solutions grounded in science to ensure that medications are safe and easy to use for people around the world – because human health matters. Every day, more than 4,700 people from 65 nations work at SCHOTT Pharma to contribute to global healthcare. The company has 17 manufacturing sites across major pharmaceutical hubs in Europe, the Americas and Asia. SCHOTT Pharma maintains a diverse portfolio of injectable drug containment and delivery solutions. These solutions range from prefillable glass and polymer syringes, cartridges, vials and ampoules. The company has focused on developing innovations for future technologies by: • Creating over 1000 patents and technologies developed in-house • Building a state-of-the-art Research and Development Center in Switzerland • Absorbing over 130 professionals focused on Research and Development Despite being a pharmaceutical manufacturer, SCHOTT Pharma aims to become climate-neutral by 2030. The company commits to this through sustainable development approaches in the society and the environment. Based in Mainz, Germany, it is part of SCHOTT AG that falls under the Carl Zeiss Foundation. SCHOTT Pharma has over 1700 global customers, 30 of which are the leading pharmaceutical manufacturers of injectable drugs. These customers have generated combined sales of EUR 899 million in the fiscal year 2023. Contact us now: pharma@schott.com Data protection: https://www.schott-pharma.com/en/legal-social